Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
1856 |
|
| Actual shortage: | 47 (3%) | |
| Anticipated shortage: | 6 (0%) | |
| Avoided shortage: | 13 (1%) | |
| Resolved: | 1790 (96%) | |
Discontinuation Reports |
82 |
|
| To be discontinued: | 1 (1%) | |
| Discontinued: | 79 (96%) | |
| Reversed: | 2 (2%) | |
Late reports |
439 (23%) |
|
Overdue reports |
1 (2%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SANDOZ RIVASTIGMINE | 1.5MG | CAPSULE | Resolved | 2023-03-06 | 2023-04-05 | 186300 |
| SANDOZ RIVASTIGMINE | 3MG | CAPSULE | Resolved | 2023-03-13 | 2023-04-05 | 186981 |
| SANDOZ RIVASTIGMINE | 1.5MG | CAPSULE | Resolved | 2023-03-27 | 2023-04-05 | 188070 |
| SANDOZ RIVASTIGMINE | 1.5MG | CAPSULE | Anticipated shortage | 2024-06-17 | 2024-06-17 | 230768 |
| SANDOZ RIVASTIGMINE PATCH 10 | 9.5MG | PATCH | Resolved | 2023-04-21 | 2023-06-07 | 190154 |
| SANDOZ RIVASTIGMINE PATCH 10 | 9.5MG | PATCH | Resolved | 2024-04-02 | 2024-05-01 | 224174 |
| SANDOZ RIVASTIGMINE PATCH 5 | 4.6MG | PATCH | Resolved | 2024-03-11 | 2024-04-16 | 221841 |
| SANDOZ RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-03-05 | 2019-06-28 | 77695 |
| SANDOZ RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-12-10 | 2020-01-22 | 100833 |
| SANDOZ RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-05-04 | 2020-06-22 | 113900 |
| SANDOZ RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-05-04 | 2020-06-22 | 113906 |
| SANDOZ RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-07-12 | 2021-07-19 | 142315 |
| SANDOZ RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-08-16 | 2021-09-21 | 144220 |
| SANDOZ RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-11-24 | 2021-11-30 | 149880 |
| SANDOZ RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-10-04 | 2022-10-20 | 171080 |
| SANDOZ RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-10-04 | 2022-10-20 | 171083 |
| SANDOZ RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-01-23 | 2024-04-04 | 217053 |
| SANDOZ RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-02-20 | 2024-03-12 | 219984 |
| SANDOZ ROSUVASTATIN | 5MG | TABLET | Resolved | 2017-09-07 | 2017-10-25 | 21337 |
| SANDOZ ROSUVASTATIN | 10MG | TABLET | Resolved | 2017-11-14 | 2018-04-13 | 29168 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ZOFRAN ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2022-12-08 | 2023-03-14 | 177540 |
| ZOFRAN ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2023-03-14 | 2023-03-14 | 187062 |